B-CELL MATURATION ANTIGEN (BCMA) TARGETED THERAPIES MARKET ANALYSIS

B-cell Maturation Antigen (BCMA) Targeted Therapies Market, by Product Type (CAR-T cell, Bispecific Antibodies, and Antibody Drug Conjugates), by Indication (Acute Lymphoblastic Leukemia, and Multiple Myeloma), and by Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published In : Oct 2017
Code : CMI190
Pages :130
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Key players in the market are focused on product development and conducting preclinical and clinical trials to assess the efficacy of these products mainly through the safety profile offered by these therapies.

Key players operating in the development of B-cell maturation antigen (BCMA) targeted therapies market are Celgene Corporation, GlaxoSmithKline plc., Novartis AG, Juno Therapeutics, Gilead Sciences. Inc., Amgen Inc., Affimed N.V, Poseida Therapeutics, Inc., and Autolus Ltd.